文献速递角膜与眼表疾病神经眼科白内障与屈光手术

阿尔茨海默病的眼部生物标志物:眼前段的作用与未来方向

Ocular Biomarkers of Alzheimer's Disease: The Role of Anterior Eye and Potential Future Directions.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2018-01-01

本文综述了眼前段结构(晶状体、角膜、房水)作为阿尔茨海默病(AD)生物标志物的研究现状。视网膜最受关注,但眼前段更易活体成像,晶状体Aβ沉积尚需验证,角膜神经与结膜血管值得探索。

要点

  • 眼前段(晶状体、角膜、房水)比视网膜更易活体成像与检查。
  • 晶状体Aβ是否积累并反映脑病理改变,尤其临床前AD,尚需研究确认。
  • 角膜神经网络与结膜血管系统可作为未来AD相关改变的研究方向。

核心结论

  • 眼前段结构有望成为AD生物标志物来源,但晶状体Aβ积累与脑病理的关联尚未确认。

研究设计与样本

  • 本文为叙述性综述,汇总当前关于眼前段(晶状体、角膜、房水)在AD中变化的文献。

主要发现

  • 视网膜是目前AD眼部标志物研究关注最多的组织,主要检测Aβ特征。
  • 晶状体受到较多关注,但Aβ是否积累及是否镜像脑神经病理改变尚需进一步研究确认。
  • 角膜神经网络与结膜血管系统在AD中的潜在关联值得未来研究探索。

临床怎么用

  • 眼前段因活体成像与检查可及性更高,可作为AD生物标志物研究的补充方向。

局限性

  • 晶状体Aβ积累与脑病理改变的关系尚未确认,尤其缺乏临床前AD的证据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Globally, Alzheimer's disease (AD) is a growing health and economic challenge that has no effective cure. Recent clinical trials indicate that preclinical treatment may be required but a routine screening tool for AD has been elusive. Hence, a simple, yet sensitive biomarker for preclinical AD, when the disease is most likely to be amenable to treatment, is lacking. Due to several features, the eye has been explored for this purpose and, among the ocular tissues, the retina has received the most attention. Currently, major works investigating the potential AD diagnosis by detecting amyloid-β (Aβ) signatures in the retinal tissue are underway, while the anterior eye is more accessible for in vivo imaging and examination. This report provides a concise review of current literature on the anterior eye components, including the crystalline lens, cornea, and aqueous humor, in AD. We also discuss the potential for assessment of the corneal nerve structure and regeneration as well as conjunctival tissue for AD-related alterations. The crystalline lens has received considerable attention, but further research is required to confirm whether Aβ accumulates in the lens and whether it mirrors brain neuropathologic changes, particularly in preclinical AD. The rich corneal neural network and conjunctival vasculature also merit exploration in future studies to shed light on their potential association with AD pathologic changes.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Dehghani C, Frost S, Jayasena R, et al. Ocular Biomarkers of Alzheimer's Disease: The Role of Anterior Eye and Potential Future Directions. Invest Ophthalmol Vis Sci. 2018. PMID: 30025102. doi:10.1167/iovs.18-24694

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。